Eli Lilly & Co. sees 60% sales increase for weight-loss drug in India, tapping into growing demand for anti-obesity solutions ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

Eli Lilly & Co. sees 60% sales increase for weight-loss drug Mounjaro in India, tapping into growing market demand.

The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.

We have five products that will launch in the next 12-18 months. We recently launched Yesintek in the immunology space -- a ...

Biologics Contract Manufacturing Market Explore the booming biologics contract manufacturing market, set to reach $83.47B by 2033, driven b ...

Biocon on Tuesday said it received approval from the government authorities for a generic diabetes medication – Liraglutide ...